Former Roche oncology head joins AAA board
This article was originally published in Scrip
Molecular nuclear medicines specialist, Advanced Accelerator Applications (AAA), has appointed Kapil Dhingra to its board of directors as an independent non-executive director. Prior to joining the AAA board, Dr Dhingra was head of oncology at Roche. He is currently head of KAPital Consulting, a healthcare consulting firm he founded in 2008, and is an advisor or member of several biotechnology and pharmaceutical companies' boards. Saint-Genis-Pouilly, France-based AAA's board is chaired by Claudio Costamagna and consists of nine directors.